Effects of PDE-5 inhibitor on pulmonary macro- and microcirculation

被引：0

作者：

Milekhin, V. ^{[1
]}

Pizanis, N. ^{[1
]}

Maykan, R. ^{[1
]}

Butrous, G. ^{[2
]}

Jakob, H. ^{[1
]}

Kamler, M. ^{[1
]}

机构：

[1] Univ Hosp Essen, W German Heart Ctr Essen, Essen, Germany

[2] Pfizer Labs, Sandwich, Kent, England

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2006年 / 25卷 / 02期

关键词：

D O I：

10.1016/j.healun.2005.11.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S62 / S62

页数：1

共 50 条

[1] Effects of PDE-5 inhibitor on pulmonary macro- and microcirculation
Milekhin, V.
Pizanis, N.
Kaiser, K.
Maykan, R.
Butrous, G.
Jakob, H.
Kamler, M.
JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 81 - 81
[2] MULTIFUNCTIONALILTY OF SILDENAFIL, AN PDE-5 INHIBITOR - PULMONARY VASODILATATION AND BEYOND
Saji, Tsutomu
JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 45 - 45
[3] COMPARISON OF THE EFFECTS AND SIDE EFFECTS BETWEEN PDE-5 INHIBITORS COMBINED WITH DAPOXETINE AND SINGLE PDE-5 INHIBITOR FOR PATIENTS WITH PREMATURE EJACULATION COMORBID ERECTILE DYSFUNCTION
Peng, J.
Zhang, Z. C.
JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S188 - S188
[4] TREATMENT PATTERNS AMONG PATIENTS PRESCRIBED PDE-5 INHIBITOR MONOTHERAPY FOR PULMONARY HYPERTENSION
Yeaw, J.
Lickert, C.
Drake, W.
De, A. P.
Wade, R. L.
VALUE IN HEALTH, 2016, 19 (03) : A59 - A59
[5] The effects of PDE-5 inhibitor on oxytocin expression and cell proliferation in cns of rats
Kim, Khae H.
Park, Heung J.
Kwon, Chil H.
Kim, Young S.
Yoon, Sang J.
Bae, Jae Hkun
Yeo, Jung K.
Shin, Mal S.
Ko, I. G.
Kim, Chang J.
JOURNAL OF UROLOGY, 2007, 177 (04): : 266 - 266
[6] Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat
Poch, David S.
BMC PULMONARY MEDICINE, 2016, 16
[7] Michel Safar, the macro- and the microcirculation
Struijker-Boudier, H.
ARTERY RESEARCH, 2009, 3 (02) : 51 - 51
[8] Michel Safar, the macro- and the microcirculation
H. Struijker-Boudier
Artery Research, 2009, 3 (2) : 51 - 51
[9] Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat
David S. Poch
BMC Pulmonary Medicine, 16
[10] PDE-5 inhibitor treatment may give patients with severe pulmonary hypertension a survival benefit
不详
RESPIROLOGY, 2015, 20 (05) : 849 - 849

← 1 2 3 4 5 →